Prostacyclin Receptor Agonist ( DrugBank: Prostacyclin )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
86	肺動脈性肺高血圧症	2

86. 肺動脈性肺高血圧症

---

臨床試験数 : 1,205 /  薬物数 : 684 - (DrugBank : 124) / 標的遺伝子数 : 100 - 標的パスウェイ数 : 193

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05427162 (ClinicalTrials.gov)	June 21, 2022	16/6/2022	A Study of Single and Multiple Doses of Different Formulations of a Prostacyclin Receptor Agonist	Open-Label, Randomized Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of Different Formulations of an IP Receptor Agonist	Pulmonary Arterial Hypertension	Drug: Prostacyclin Receptor Agonist	Actelion	NULL	Recruiting	18 Years	55 Years	All	86	Phase 1	United States
2	EUCTR2016-003495-53-NL (EUCTR)	29/11/2016	15/12/2016	Study on the effect of the drug selexipag in adult patients with elevated pressure in the pulmonary arteries due to a cardiac birth defect	Prostacyclin receptor agonist Selexipag in patients with pulmonary arterial hypertension and congenital heart disease - SELECT trial	Pulmonary arterial hypertension related to congenital heart disease.;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]	Trade Name: Selexipag Product Name: Selexipag	Academic Medical Center - Cardiology	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes		Phase 3	Netherlands